Research and Development Prospect of China Dialysis Market, 2013-2017

News provided by

Nov 14, 2013, 08:00 ET

NEW YORK, Nov. 14, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Research and Development Prospect of China Dialysis Market, 2013-2017

http://www.reportlinker.com/p01187425/Research-and-Development-Prospect-of-China-Dialysis-Market-2013-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment

"Research and Development Prospect of China Dialysis Market, 2013-2017" firstly conducts a profound analysis on the market status, policy environment, existing problems and favorable factors of China's dialysis industry; this report also summarizes the latest development situation of international and domestic key enterprise, and finally launches a forecast for this industry's future development, which can provide decision-making reference for the enterprises and investors.

In 2012, the scale of China's dialysis market was about CNY 12 billion, of which, the scale of hemodialysis market and peritoneal dialysis was about CNY 10 billion and CNY 2 billion respectively. In China, hemodialysis has been very popular in China, and there are about 1,000 hospitals have carried out this treatment.

Fresenius in Germany, Nikkiso in Japan, Baxter in the United State, Cambro in Sweden, Asahi Kasei in Japan and some other foreign-funded enterprises lead the development of China's dialysis market. The domestic enterprises mainly produce some low-tech products, such as dialysis circuit tube and dialyzate; rare domestic enterprises can produce dialyzer, dialysis machine and other high-end products. Among current domestic enterprises, Weigao is the leader in the field of hemodialysis machine and Huaren Pharmaceutical is the leader in the peritoneal dialysis field.

Table of Contents

1. Overview of Dialysis Market
1.1 Definition
1.2 Classification
1.3 Development History

2. Global Dialysis Market
2.1 Morbidity of Chronic Renal Failure
2.2 Dialysis Product Market
2.3 Treatment Cost

3. Status Quo of China's Dialysis Market
3.1 Development Status
3.2 Policy Environment
3.2.1 Medical Insurance Leans to Uremia, the Reimbursement Proportion Was Raised
3.2.2 Introduction of Hemodialysis Industrial Standard
3.2.3 Related Peritoneal Dialysis Policies
3.3 Favorable Factors
3.4 Existing Problems
3.4.1 Excessive Government Regulation Increases the Treatment Costs
3.4.2 Medical Market Access Was Limited; Large-scale Hospitals Monopolize Hemodialysis Equipments; It is Difficult to Form Price Competition
3.4.3 Family Hemodialysis is Restricted by Policy, Reimbursement and Some Other Issues

4. Overview of Subdivided Industries
4.1 Dialyzer
4.2 Dialysis Machine
4.3 Hemodialysis Solutions

5. Import and Export of Dialysis Equipments
5.1 Import
5.2 Export

6. Key Overseas Production Enterprises
6.1 Fresenius (Germany)
6.1.1 Company Profile
6.1.2 Business Development
6.1.3 Business Performance
6.1.4 Business in China
6.1.5 Outlook
6.2 Nikkiso (Japan)
6.2.1 Company Profile
6.2.2 Main Products
6.2.3 Business Performance
6.3 Baxter (the United States)
6.3.1 Company Profile
6.3.2 Operation Status
6.3.3 Renal Dialysis Business
6.3.4 Operation in China
6.4 Asahi Kasei (Japan)
6.4.1 Company Profile
6.4.2 Operation Status of Medical Care Department
6.4.3 Operation in China
6.4.4 Development Strategy and Goal
6.5 B.Braun (Germany)
6.5.1 Company Profile
6.5.2 Operation Status
6.5.3 Dialysis Department
6.5.4 Business in China
6.6 NxStage (the United States)
6.6.1 Company Profile
6.6.2 Operation Status
6.6.3 Portable Hemodialysis Machine Business
6.6.4 Hemodialysis Consumable Business
6.7 Gambro (Sweden)
6.7.1 Company Profile
6.7.2 Operation Status
6.7.3 Business in China

7. Key Domestic Production Enterprises
7.1 Weigao Group
7.1.1 Company Profile
7.1.2 Dialysis Products
7.1.3 Channel Development
7.1.4 Hemodialysis Business
7.1.5 Peritoneal Dialysis Business
7.2 Huaren Pharmaceutical Co., Ltd.
7.2.1 Company Profile
7.2.2 Operation Status
7.2.3 Peritoneal Dialysis Business
7.2.4 R&D and Marketing of New Products
7.2.5 Business Plan in 2013
7.3 Boxlight
7.3.1 Company Profile
7.3.2 Operation Status
7.3.3 Hemodialysis Business
7.3.4 Development of New Hemodialysis Equipments
7.3.5 Development Plan of Hemodialysis Channel
7.4 Kelun Pharmaceutical
7.4.1 Company Profile
7.4.2 Main Products
7.4.3 Operation Status
7.4.4 Peritoneal Dialysis Business
7.4.5 Development Strategy
7.5 Jihua Medical Apparatus and Instruments Co., Ltd.
7.5.1 Company Profile
7.5.2 Product Research and Development
7.5.3 Hemodialysis Business
7.5.4 SWOT
7.5.5 Development Strategy
7.6 Bain Medical Equipment Co., Ltd.
7.6.1 Company Profile
7.6.2 Competitive Advantages
7.6.3 Development Planning
7.7 Jiangsu Lengthen Life Science and Technology Co., Ltd.
7.7.1 Company Profile
7.7.2 Production and Operation Status
7.7.3 Development Strategy
7.8 Guangzhou Koncen Biotechnology Co., Ltd.
7.8.1 Company Profile
7.8.2 Production and Operation Status
7.8.3 Development Planning

8. Investment Analysis and Suggestions of China's Dialysis Industry
8.1 Development Prospect
8.2 Investment Opportunity
8.3 Suggestions from Industrial Experts
8.3.1 Vigorously Develop Small-scale Portable Equipments
8.3.2 Ensure the Medical Safety through Strict Standardized Training
8.3.3 Complete Family Hemodialysis Related Reimbursement Policies
8.3.4 Open the Market Access; Allow Private Capital to Establish Hemodialysis Center; Standardize Related Detailed Rules
8.3.5 Make Use of Price and Geographical Advantages; Actively Explore the Southeast Asian Markets

Companies Mentioned

Fresenius (Germany)
Nikkiso (Japan)
Baxter (the United States)
Asahi Kasei (Japan)
B.Braun (Germany)
NxStage (the United States)
Gambro (Sweden)
Huaren Pharmaceutical Co., Ltd.
Boxlight
Kelun Pharmaceutical
Jihua Medical Apparatus and Instruments Co., Ltd.
Bain Medical Equipment Co., Ltd.
Jiangsu Lengthen Life Science and Technology Co., Ltd.
Guangzhou Koncen Biotechnology Co., Ltd.